The main issues in relation to the vaccination of animals is access and availability. Vaccines are the most cost-effective measure in preventing disease in livestock populations, although the logistics of distributing vaccines to marginalised populations is still a challenge.
Accessibility Most
smallholder farmers' (SHFs) livestock in marginalised populations (MPs) die as a result of a disease, they do not reach their full potential, or they transmit a disease. The root of this issue could be prevented or controlled by increasing the accessibility to animal vaccines. Livestock are necessary to an estimated 600 to 900 million poor farmers in the developing world. This is because the animals provide food, income, financial reserve and status.
Availability The diseases have been characterised into diseases that cause economic losses, government-controlled diseases, and neglected diseases, which all link to availability. The economic losses category entails necessary vaccines in developing countries normally produced by the private sector that make little to no profit, these companies require community support to continue producing. Whereas, government-controlled diseases are controlled by government policy, the main issue here is if the vaccine is expensive it therefore becomes less available to poor farmers. Furthermore, there are some animal diseases which have been neglected as they mainly only affect poor communities, and thus will not be profitable. This is because producers target the largest markets first to ensure their return on investment (ROI). For example, the reason why dog transmitted rabies is taking time to eradicate is because it only affects the developing world, thus it is not able to be produced on a large and profitable scale.
Other issues Some other issues include but are not limited to: economic barriers, political barriers, technical and scientific barriers, regulatory barriers, field use barriers, and social and perception barriers. == Possible solutions ==